Biotech · Private company
Nicox Ophthalmics, Inc.
Track this companyFree. Adds Nicox Ophthalmics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- Latanoprost 0.005%Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Latanoprost 0.005% (initial phase of trial)Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Latanoprost 0.005% (remainder of trial)Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470 0.065% (initial phase of trial)Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470 0.1%Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470 0.1% (initial phase of trial)Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470 0.1% (remainder of trial)Phase 3 · Open Angle GlaucomaClinicalTrials.gov · fetched Nov 12, 2026
- Fluticasone PropionatePhase 2 · BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- Latanoprost 0.005%Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
- NCX 4251Phase 2 · BlepharitisClinicalTrials.gov · fetched Nov 12, 2026
- NCX 470Phase 2 · Glaucoma, Open-AngleClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Aqueous Humor Dynamics of NCX 470 Ophthalmic SolutionPHASE2_PHASE3 · COMPLETED · started Dec 12, 2023ClinicalTrials.gov NCT05938699 · fetched Nov 12, 2026
- Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of BlepharitisPHASE2 · COMPLETED · started Dec 14, 2020ClinicalTrials.gov NCT04675242 · fetched Nov 12, 2026
- MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionPHASE3 · COMPLETED · started Nov 9, 2020ClinicalTrials.gov NCT04630808 · fetched Nov 12, 2026
- Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionPHASE3 · COMPLETED · started Jun 1, 2020ClinicalTrials.gov NCT04445519 · fetched Nov 12, 2026
- Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of BlepharitisPHASE2 · COMPLETED · started Mar 18, 2019ClinicalTrials.gov NCT03926026 · fetched Nov 12, 2026
- Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular HypertensionPHASE2 · COMPLETED · started Aug 1, 2018ClinicalTrials.gov NCT03657797 · fetched Nov 12, 2026